Does DUPILUMAB Cause Therapy interrupted? 377 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 377 reports of Therapy interrupted have been filed in association with DUPILUMAB (Dupixent). This represents 0.1% of all adverse event reports for DUPILUMAB.
377
Reports of Therapy interrupted with DUPILUMAB
0.1%
of all DUPILUMAB reports
2
Deaths
44
Hospitalizations
How Dangerous Is Therapy interrupted From DUPILUMAB?
Of the 377 reports, 2 (0.5%) resulted in death, 44 (11.7%) required hospitalization.
Is Therapy interrupted Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DUPILUMAB. However, 377 reports have been filed with the FAERS database.
What Other Side Effects Does DUPILUMAB Cause?
Pruritus (44,279)
Dermatitis atopic (33,670)
Product use in unapproved indication (33,452)
Rash (30,895)
Injection site pain (27,799)
Drug ineffective (23,712)
Dry skin (20,239)
Eczema (20,020)
Product dose omission issue (18,189)
Condition aggravated (16,459)
What Other Drugs Cause Therapy interrupted?
ADALIMUMAB (5,755)
ETANERCEPT (3,397)
RELUGOLIX (3,251)
CERTOLIZUMAB PEGOL (3,209)
LENALIDOMIDE (2,724)
UPADACITINIB (1,741)
ABATACEPT (1,726)
CLOZAPINE (1,722)
AMIKACIN (1,283)
TOFACITINIB (1,182)
Which DUPILUMAB Alternatives Have Lower Therapy interrupted Risk?
DUPILUMAB vs DURAGESIC
DUPILUMAB vs DUROGESIC
DUPILUMAB vs DUROTEP MT
DUPILUMAB vs DURVALUMAB
DUPILUMAB vs DUTASTERIDE